One of the assets that Lantheus has taken was LRRC15 antibody for osteosarcoma (aggressive bone cancer).
It has both ODD and RPDD from the FDA.
I hope we don't regret selling it cheap.
- Forums
- ASX - By Stock
- Ann: Radiopharm Receives Strategic Investment for up to A$18 mill
One of the assets that Lantheus has taken was LRRC15 antibody...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.01M |
Open | High | Low | Value | Volume |
3.5¢ | 3.5¢ | 3.5¢ | $29.13K | 832.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 275460 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 414155 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 275460 | 0.035 |
9 | 777410 | 0.034 |
5 | 644693 | 0.033 |
2 | 281245 | 0.032 |
4 | 1730000 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 414155 | 4 |
0.037 | 175000 | 2 |
0.038 | 351262 | 1 |
0.039 | 600000 | 2 |
0.040 | 354900 | 3 |
Last trade - 12.39pm 08/07/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |